The OGI Genomics Core facility was established in April of 2013 by the Massachusetts Eye and Ear Infirmary’s Department of Ophthalmology, with the goal of offering advanced genomics analysis methods and techniques to MEEI’s clinical research staff and affiliates. This investment in instrumentation, infrastructure, and personnel has resulted in a facility capable of performing multiple and varied genomics analyses from experimental design to data analysis and interpretation.
Services provided by the Genomics core:
- Sanger sequencing
- Whole exome sequencing
- Selective exon capture and next generation sequencing (NGS) for ocular disease genes (RetNeT, glaucoma, optic neuropathy, mitochondrial DNA)
- Genome-wide genotyping (both common and rare variation)
- Copy number variation (CNV) using array CGH (comparative genomic hybridization), high-density genotypes and MLPA (multiplex ligation-dependent probe amplification)
- RNA sequencing (RNA-seq) for transcriptome analyses
Contacts:
Eric A. Pierce (Eric_Pierce@meei.harvard.edu)
Hilary_Scott (Hilary_Scott@meei.harvard.edu)
Ordering Services and More Information:
For more information about our facilities, genomics services, scheduling a consultation, pricing, or to submit an analysis request, please contact Hilary Scott, Associate Director at OGICore@meei.harvard.edu or “Hilary_Scott@meei.harvard.edu”